Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches
Authors:
- Matthew A. HuntMHMatthew A. Hunt
- Kristoph JahnkeKJKristoph Jahnke
- Tulio P. MurilloTMTulio P. Murillo
- Edward A. NeuweltENEdward A. Neuwelt
Open Access
- 1 November 2006
- journal article
- case report
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 21 (5) , 1-7
Abstract
Object: White matter diseases, including demyelinating or inflammatory disorders, may be indistinguishable clinically and radiologically from some central nervous system (CNS) tumors. In such situations, determination of the final diagnosis is difficult. An example is the differential diagnosis of non-acquired immunodeficiency syndrome–related primary central nervous system lymphoma (PCNSL) and multiple sclerosis (MS), a demyelinating disease. Unfortunately, delayed diagnosis and treatment of PCNSL can negatively affect prognosis. Methods: The authors reviewed the cases of eight patients with PCNSL or MS. In each case, the initial diagnosis (PCNSL or MS) was equivocal. In these cases, conventional diagnostic approaches were not definitive, thus further delaying diagnosis. The initial symptoms, the selected diagnostic tests, and the presumptive as well as final diagnosis for each case are discussed. The final diagnosis was PCNSL in six cases and MS in two. The uncertainty about the clinical or initial pathological presentation required further diagnostic evaluation in all cases. Two important neurosurgical guidelines are the avoidance of corticosteroid agents and performance of biopsy sampling rather than volumetric tumor resection. High-volume lumbar puncture, slit-lamp examination/vitrectomy, new CNS imaging techniques, and repeated biopsy procedures also proved helpful. Conclusions: In PCNSL, early definitive diagnosis and treatment are the keys to successful outcomes. Knowledge of strategies essential to early diagnosis lessens the need for brain biopsy sampling, but this procedure is still usually necessary. In such selected cases, biopsy sampling is appropriate even when pathological investigation shows MS rather than PCNSL. Complete resection is not indicated in PCNSL and can lead to additional sequelae.Keywords
This publication has 33 references indexed in Scilit:
- Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS LymphomaJournal of Clinical Oncology, 2005
- Vanishing contrast enhancement in malignant glioma after corticosteroid treatmentActa Neurochirurgica, 2004
- Primary central nervous system lymphomasCurrent Opinion in Neurology, 2003
- Current Status and Future of Relapsed Primary Central Nervous System Lymphoma (PCNSL)Leukemia & Lymphoma, 2003
- A comparison between ventricular and lumbar cerebrospinal `uid cytology in adult patients with leptomeningeal metastasesNeuro-Oncology, 2001
- Cognitive Outcomes and Long-term Follow-up Results after Enhanced Chemotherapy Delivery for Primary Central Nervous System LymphomaNeurosurgery, 2000
- Sentinel lesions of primary CNS lymphoma.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasiaActa Neurologica Scandinavica, 1992
- Primary non-Hodgkin's lymphomas of the CNSActa Neurologica Scandinavica, 1986
- Primary cerebral lymphoma: the “ghost tumor”Journal of Neurosurgery, 1984